Pricing

NEPHROGENEX INC COM (NRXGQ)

followers ·
Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
John P. Hamill
Employees:
1700
P.O. BOX 400, JAMISON, PA, 18929
6095538887

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • NephroGenex
NephroGenex, Inc. is a pharmaceutical company, which focuses on the development of therapeutics to treat kidney disease, an area of significant unmet medical need. It is developing Pyridorin, a small molecule drug that is acting inhibitor of the pathogenic oxidative chemistries which are elevated in diabetic patients. The company was founded by Billy G. Hudson, J. Wesley Fox Ahmann and Tryggvason Karl on May 25, 2004 and is headquartered in Raleigh, NC.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available